Description

10 μg dose vaccine: 1 dose (0.5 ml) contains: Hepatitis B surface antigen1, 2 10 micrograms.
1Adsorbed on aluminium hydroxide, hydrated; Total: 0.25 milligrams Al3+.
2Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology.
20 μg dose vaccine: 1 dose (1 ml) contains: Hepatitis B surface antigen1, 2 20 micrograms.
1Adsorbed on aluminium hydroxide, hydrated; Total: 0.50 milligrams Al3+.
2Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology.
The vaccine is highly purified, and exceeds the WHO requirements for recombinant hepatitis B vaccines. No substances of human origin are used in its manufacture.
Upon storage, a fine white deposit with a clear colourless supernatant may be observed.
Excipients/Inactive Ingredients: Monodose presentation: Sodium chloride, sodium phosphate dihydrate, sodium dihydrogen phosphate, water for injections.
Polysorbate 20 is present as residual from the manufacturing process.
Multidose presentation: Sodium chloride, sodium phosphate dihydrate, sodium dihydrogen phosphate, water for injections, 2-phenoxyethanol as preservative.
Polysorbate 20 is present as residual from the manufacturing process.